+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2016-01-13Number of Pages: 101

Parenteral Nutrition Market (Type of Nutrient - Carbohydrates, Parenteral Lipid Emulsion, Single Dose Amino Acid Solutions, Trace Elements, and Vitamins and Minerals) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024

The progress of the global parenteral nutrition market is based on the high prevalence of chronic conditions across the globe. The rise in cancer, AIDS, diabetes, Crohn’s disease, gastro-intestinal disorders, and short bowel syndrome cases has also led a growth in the consumption of parenteral nutrition in the recent years. The World Health Organization (WHO) affirmed this fact with statistics indicating that there will be a 70% rise in the number of new cancer cases between 2025 and 2035. The Crohn’s & Colitis Foundation of America also provided grim figures indicating that there will be 70,000 new cases of Crohn’s disease each year. Thus, the rising health complications will propel the demand for parenteral nutrition across health facilities.

These supportive factors are expected to create an opportunity for this market, which will be worth US$6.9 bn by 2023 as compared to US$4.1 bn in 2014. Between the years 2015 and 2023, this market is expected to expand at a CAGR of 5.7%.

North America Accounted for Over 40% of the Parenteral Nutrition Market in 2014

North America was the leading geographical segment in the global parenteral nutrition market as of 2014, accounting for nearly 40.1% share. The high rate of approvals from the U.S. FDA and supportive insurance policies that cover expenditure on parenteral nutrition are expected to keep this region in the leading position during the forecast period. The North America parenteral nutrition market that comprises the U.S. and Canada will also be driven by rising number diabetes and cancer cases. Furthermore, companies are also trying to expand their operations in Canada to gain a stronger foothold by meeting the unmet needs of the patients.

Meanwhile, the parenteral nutrition market in Asia Pacific is expected to surge at the highest pace of 7.3% CAGR between 2015 and 2023. The emerging economies and developing pharmaceutical markets of countries such as China, India, Indonesia, Singapore, Taiwan, and Thailand amongst others are expected to encourage the growth of this market within Asia Pacific. The rising cases of preterm birth, which leads to malnutrition is the prime reason for rising consumption of parenteral nutrition in Asia Pacific.

Single Dose Amino Acid Solutions Nutrients is Most Attractive Product Segment

Out of all the products available in the global parenteral nutrition market, the single dose amino acid solutions nutrient segment captured a significant share of 34.14% in 2014. Research indicates that this segment will be the leading nutrient segment as several leading players are introducing unique amino acid-based PN products. The abundant availability of these products is expected to be the main reason for their soaring success in the forecast period. Reports also suggest that the parenteral lipid emulsion nutrient segment will grow at the highest CAGR of 6.2% amongst all other nutrient segments between 2015 and 2023.

The leading players shaping the vendor landscape of the global parenteral nutrition market are Sichuan Kelun Pharmaceutical Co., Ltd., Allergan plc (Actavis plc), Fresenius SE & Co. KGaA, Grifols S.A., Baxter International, Inc., Claris Lifesciences Limited, and B. Braun Melsungen AG, Pfizer, Inc. (Hospira, Inc.) amongst others. Companies are trying to seek approvals for their new parenteral nutrition formulations from concerned authorities such as the U.S. FDA to launch new products in the market. This effort is focused at both grabbing new market shares and providing for the deficit of parental nutrition in developing regions.

Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.4 Assumptions

Chapter 2 Executive Summary
2.1 Global Parenteral Nutrition Market: Market Snapshot
2.2 Global Parenteral Nutrition Market Revenue, by Type of Nutrient, 2014 (US$ Mn)
2.4 Global Parenteral Nutrition Market Share, by Geography (Value %)

Chapter 3 Global Parenteral Nutrition Market– Industry Analysis
3.1 Introduction
3.2 Market Dynamics
       3.2.1 Market Driver
                3.2.1.1 Increase in incidence of chronic diseases
                3.2.1.2 Rise in cases of malnutrition
                3.2.1.3 Approvals of novel parenteral nutrition combinations
                3.2.1.4 Aging population
       3.2.2 Market Restraint
                3.2.2.1 Side effects or complications related to parenteral nutrition products
       3.2.3 Market Opportunity
                3.2.3.1 Expanding footprint in emerging nations that offer sustained growth opportunities
3.3 Porter’s Five Forces Analysis: Global Parenteral Nutrition Market
3.4 Event Impact Analysis: Global Parenteral Nutrition Market
3.5 Market Attractiveness Analysis: Global Parenteral Nutrition Market
3.6 Global Market Share – Parenteral Nutrition Market (2014) (%)
       3.6.1 North America Market Share – Parenteral Nutrition Market (2014) (%)
       3.6.2 Europe Market Share – Parenteral Nutrition Market (2014) (%) 
       3.6.3 Asia Pacific Market Share – Parenteral Nutrition Market (2014) (%)
       3.6.4 Latin America Market Share – Parenteral Nutrition Market (2014) (%)
       3.6.5 Middle East & Africa Market Share – Parenteral Nutrition Market (2014) (%)
       3.6.6 Market Share - Carbohydrates Parenteral Nutrition Market (2014) (%)
       3.6.7  Market Share - Parenteral Lipid Emulsion Parenteral Nutrition Market (2014) (%) 
       3.6.8  Market Share - Single Dose Amino Acids Parenteral Nutrition Market (2014) (%) 
       3.6.9 Market Share - Other Parenteral Nutrition Products Market (2014) (%) 

Chapter 4 Market Segmentation - By Type of Nutrient
4.1 Introduction
4.2 Global Parenteral Nutrition Market Revenue, by Types of Nutrient, 2013–2023, (US$ Mn)
       4.2.1 Global Carbohydrates Market Revenue, 2013–2023, (US$ Mn)
       4.2.2 Global Parenteral Lipid Emulsions Market Revenue, 2013–2023, (US$ Mn)
       4.2.3  Global Single Dose Amino Acid Solutions Market Revenue, 2013–2023, (US$ Mn)
       4.2.4 Global Trace Elements Market Revenue, 2013–2023, (US$ Mn)
       4.2.5 Global Vitamins and Minerals Market Revenue, 2013–2023, (US$ Mn)

Chapter 5 Market Segmentation – By Geography
5.1 Global Parenteral Nutrition Market Revenue, by Geography, 2013–2023 (US$ Mn)
5.2 North America Parenteral Nutrition Market Revenue, by Country, 2013–2023 (US$ Mn)
5.3 Europe Parenteral Nutrition Market, by Country, 2013–2023 (US$ Mn)
5.4 Asia Pacific Parenteral Nutrition Market Revenue, by Country, 2013–2023 (US$ Mn)
5.5 Latin America Parenteral Nutrition Market Revenue, by Country, 2013–2023 (US$ Mn)
5.6 Middle East & Africa Parenteral Nutrition Market Revenue, by Country, 2013–2023 (US$ Mn)

Chapter 6 Recommendations
6.1 Expand presence in developing economies
6.2 Increase in research and development activities
6.3 Long-term contract with hospitals and community care centers

Chapter 7 Company Profiles
7.1 Allergan plc (Actavis plc)
7.2 Baxter International, Inc.
7.3 B. Braun Melsungen AG
7.4 Claris Lifesciences Limited
7.5 Fresenius SE & Co. KGaA
7.6 Grifols S.A.
7.7 Pfizer, Inc. (Hospira, Inc.)
7.8 Sichuan Kelun Pharmaceutical Co., Ltd.

Parenteral Nutrition Market: Overview

As per the World Health Organization (WHO), approximately 11% of the diseases globally are taking place owing to malnutrition and hence are posing a risk to the life of human beings. If this count increases in forthcoming years, then problems of food security and political unrest will emerge, providing impetus to the development of the global parenteral nutrition market.

The report covers a detailed understanding of the forces driving and restraining the development of the global parenteral nutrition market. Market attractiveness analysis also forms a key part of this report in addition to the employment of tools such as Porter’s five forces model in order to present the degree of competition prevalent in the market. Furthermore, market share analysis with respect to different regions also forms an integral part of this study.

The top segments and sub-segments present in the market and their expected state by the end of the forecast period have also been presented. The competitive landscape section of the study encapsulates the leading vendors in the market, their key weaknesses and strengths, and top product introductions.

Parenteral Nutrition Market: Drivers and Restraints 

The global parenteral nutrition market is fuelled by the increasing occurrence of chronic diseases such as Crohn’s disease, diabetic complications, ischemic bowel disease, gastro-intestinal disorders, and cancer. In addition, the soaring count of malnourished children, particularly within emerging nations resulting in the increasing natality rate will positively impact the development of the global parenteral nutrition market. Furthermore, the increasing aging population suffering from deficiency of several essential nutrients will stimulate the growth of the market. 

On the other hand, the market for parenteral nutrition is restrained due to the increasing health risks incurred owing to poor monitoring. In addition, muscle pain, allergic reactions, unexplained gaining of weight, and shortness of breath are also some of the other side effects related to parenteral nutrition. Furthermore, consistent utilization of parenteral nutrition therapy may result in liver diseases and metabolic complications, as per The American Society for Nutrition. These factors will further negatively impact the growth of the global parenteral nutrition market. 

Parenteral Nutrition Market: Region-wise Outlook 

Geographically, the report segments the global parenteral nutrition market into Latin America (LATAM), Asia Pacific, Europe, North America, and the Middle East and Africa (MEA).  Of these, North America led the market for parenteral nutrition in 2014 and constituted an approximate share of 40.1%. This region is poised to maintain its superiority all through the forecast period. This is owing to the favorable insurance policies covering all the parenteral nutrition expenditures within this region. In addition, both in Canada and the U.S., the parenteral nutrition market will rise owing to increasing count of patients having cancer and diabetes. Furthermore, a number of companies have also put in efforts to increase their operations within Canada, thus boosting the growth of the North America parenteral nutrition market. 

On the other hand, the Asia Pacific parenteral nutrition market is predicted to rise at the swiftest CAGR of 7.30% from 2015 to 2023. This is owing to the advancement of pharmaceutical markets in nations such as Thailand, Taiwan, Singapore, Indonesia, China, and India. In addition, the increasing preterm birth cases, resulting in malnutrition will further boost the growth of this market in Asia Pacific. 

Key players Mentioned in the Report are: 

The leading players in the global parenteral nutrition market are Sichuan Kelun Pharmaceutical Co., Ltd., Fresenius SE & Co. KGaA, Grifols S.A., Allergan plc (Actavis plc),  Baxter International, Inc., and Pfizer, Inc. (Hospira, Inc.) amongst others. 

Major regions analyzed under this research report are: 

  • North America 
  • Asia Pacific 
  • Europe
  • Latin America
  • Middle East and Africa

This report gives you access to decisive data such as: 

  • Market growth drivers
  • Factors limiting market growth
  • Current market trends
  • Market structure
  • Market projections for the coming years 

Key highlights of this report: 

  • Overview of key market forces propelling and restraining market growth
  • Up-to-date analyses of market trends and technological improvements
  • Pin-point analyses of market competition dynamics to offer you a competitive edge
  • An analysis of strategies of major competitors
  • An array of graphics and SWOT analysis of major industry segments
  • Detailed analyses of industry trends
  • A well-defined technological growth map with an impact-analysis
  • Offers a clear understanding of the competitive landscape and key product segments


 
 
Back To Top